Skip to main content

Anixa Biosciences Inc

ANIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000715446

In the last 90 days, Anixa Biosciences Inc insiders filed 12 open-market purchases and 0 sales; 63 institutions reported holding it in 13F filings for Q2 2026, worth $15.0M in total; no superinvestor holds it.

Members of Congress who traded ANIX

No member of Congress has reported a trade in Anixa Biosciences Inc since 2020.

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.